Stratasys SSYS 深 沪
已收盘 07-31 16:00:00 美东时间
7.82
-0.210
-2.62%
华盛通- 最 高8.24
- 今 开8.09
- 成交量 36.87万股
- 最 低 7.81
- 昨 收 8.03
- 总市值 67.89万
- 52周最高 12.81
- 市盈率 静 --
- 换手率 424.76%
- 52周最低 7.34
- 委 比 -37.36%
- 总股本 8.68万
- 历史最高 138.10
- 量 比 0.97
- 振 幅 5.35%
- 历史最低 6.05
- 每 手 1
- 风险率 1.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nano Dimension ends headquarters lease, expects $25M net cash savings
Nano Dimension (NNDM) said on Friday it agreed to terminate the lease for its corporate headquarters effective Dec. 31, 2026, as part of its cost-cutting efforts. The company said ending the lease, or...
07-17 20:30
Shares of companies within the broader industrial sector are trading lower amid overall market weakness after unexpectedly strong U.S. job-growth data dampened expectations for a Fed rate cut.
Shares of companies within the broader industrial sector are trading lower amid...
06-06 03:33
9 Industrials Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
06-03 01:35
Stratasys Rises As Markforged Deal Boosts Manufacturing, Defense Expansion Plans
Stratasys shares gain after the company announces a $42.5 million Markforged acquisition to expand aerospace and defense capabilities.
05-28 00:16
Stratasys To Acquire MarkForged From Nano Dimension For $42.5M In Cash
Stratasys Ltd. (NASDAQ:SSYS), a leader in additive manufacturing solutions, today announced that it has entered into a definitive agreement to acquire MarkForged, Inc., a wholly owned subsidiary of Nano Dimension, in an
05-27 18:32
Nano Dimension Announces Sale of MarkForged, Inc. to Stratasys
Nano Dimension Ltd. has agreed to sell MarkForged, Inc. to Stratasys Ltd. for $42.5 million in cash, part of its three-phase strategic plan to maximize shareholder value. The sale, under Phase 2, is expected to reduce annual cash burn by $15 million and retain MarkForged's metal binder jetting product line. The transaction is set to close in the second half of 2026.
05-27 10:30
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
